Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy. (Q43022261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Andrew Voigt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Alaa Shalaby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Evan Adelstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Samir Saba

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

E1-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

Cardiac resynchronization in chronic heart failure

5 February 2020

cites work

1 reference

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

21 January 2018

1 reference

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

21 January 2018

1 reference

Association between performance measures and clinical outcomes for patients hospitalized with heart failure

21 January 2018

1 reference

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.

21 January 2018

1 reference

Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization

21 January 2018

1 reference

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

21 January 2018

1 reference

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study

21 January 2018

1 reference

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

21 January 2018

1 reference

Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

21 January 2018

1 reference

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20549778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prediction of response to cardiac resynchronization therapy: the selection of candidates for CRT (SCART) study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20549778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20549778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CLC.20500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549778%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

20549778

1 reference